Clinical Trial Search

Primary: Pharmacokinetics (PK): Insulin Lispro Area Under the Concentration Curve From Time Zero to 5 Hours (AUC[0-5h]) (Part A) — 719; 783 picomole*hour per liter (pmol*h/L)

Primary: Time in Target Range — 71; 59 percentage of time — p=<0.001

Primary: Serosal-anchor Measurement — 6.2 mm

Primary: Number of Participants With Tissue Samples Identified With Bacterial DNA According to Highly Sensitive Bacterial Assays — 10; 24; 20 Participants

Primary: Self Efficacy: This Will be Measured by the General Self Efficacy Scale — 24.26; 22.30 Score on a scale — p=<0.001

Primary: Change in PBR Uptake (Changes in PBR Uptake by PET) — 1.301; 1.1219 percent change from baseline

Primary: Pharmacokinetics (PK): Insulin Lispro Area Under the Concentration Curve From Time Zero to 5 Hours (AUC[0-5h]) — 918; 970; 906; 824 picomole*hour per liter (pmol•h/L)

Primary: Percentage of Participants With Objective Response Per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) as Determined by Investigator — 17.1…

Primary: Baseline Pain Assessment Before Knee Arthroscopy Via the Visual Analog Scale. — .25; .43 score on a scale

Primary: Overall Success Rate — 240 Abutments

Primary: Change in Workplace Sedentary Time — 369; 355; 229; 338 Minutes

Primary: Overall Response Rate (ORR) by Independent Review Committee (IRC) (Full Analysis Population) — 31; 34; 48 Percentage of Participants

Primary: Listening Inventory For Education Revised (LIFE-R) - Total Score — 30.91; 28.30; 33.33; 35.61 Units on a scale

Primary: T50-3 — 31.87; 63.81; 33.30; 60.82 minutes

Primary: Change From Baseline in Sequential Response Time to Post-Intervention — 8.68; 8.84; 8.32; 7.96 seconds